{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:10:56Z","timestamp":1779963056416,"version":"3.53.1"},"reference-count":6,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Overview of:<\/jats:bold>\n                    Boralevi F, Simon G, Bernigaud C,\n                    <jats:italic>et al<\/jats:italic>\n                    . Oral ivermectin vs 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.\n                    <jats:italic>BMJ<\/jats:italic>\n                    2026;392:e086277. doi: 10.1136\/bmj2025-086277.\n                  <\/jats:p>","DOI":"10.1136\/dtb.2026.000021","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:40:23Z","timestamp":1779961223000},"page":"92-92","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Optimising treatment options in scabies"],"prefix":"10.1136","volume":"64","member":"239","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2026052802401388000_64.6.92.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-086277","article-title":"Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial","volume":"392","author":"Boralevi","year":"2026","journal-title":"BMJ"},{"key":"2026052802401388000_64.6.92.2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19167"},{"key":"2026052802401388000_64.6.92.3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/09564624251321264","article-title":"British Association for Sexual Health and HIV National Guideline on the Management of Scabies in adults 2025","volume":"36","author":"Morris","year":"2025","journal-title":"Int J STD AIDS"},{"key":"2026052802401388000_64.6.92.4","unstructured":"National Institute for Health and Care Excellence . Clinical Knowledge Summaries. Available: https:\/\/cks.nice.org.uk\/topics\/scabies\/ [Accessed 10 May 2026]."},{"key":"2026052802401388000_64.6.92.5","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1111\/jdv.17339","article-title":"Is Scabies becoming less sensitive to permethrin therapy?","volume":"35","author":"Mazzatenta","year":"2021","journal-title":"Acad Dermatol Venereol"},{"key":"2026052802401388000_64.6.92.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.s380","article-title":"Evidence based choices for first line scabies treatment","volume":"392","author":"Hardy","year":"2026","journal-title":"BMJ"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2026.000021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:40:31Z","timestamp":1779961231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2026.000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":6,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,28]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/dtb.2026.000021"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2026.000021","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"value":"0012-6543","type":"print"},{"value":"1755-5248","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}